Page 44 - congress
P. 44

ORAL PRESENTATION / TAM METİN SÖZLÜ SUNUM



               evaluated  both  at  the  cellular  membrane  level  and  by  measuring  lipid  peroxidation
               products and antioxidants involved in the defense system against reactive oxygen species

               (ROS) (Manivasagam et al., 2020).
                     Glutathione (GSH) is one of the major intracellular antioxidants, acting as a reducing

               agent and protecting cells by neutralizing the harmful effects of ROS (Khaliulin et al.,

               2025). Glutathione peroxidase (GPx) is an enzyme that detoxifies peroxides using GSH
               and protects cells from oxidative stress (Bjørklund et al., 2020). According to studies by

               Meguid et al. (2011) and Frustaci et al. (2012), GPx levels were reported to be lower in
               children with ASD compared to control groups. Chauhan et al. (2012) and Rose et al.

               (2012) reported impaired GSH homeostasis and decreased GSH antioxidant levels in the
               temporal cortex and cerebellum of individuals with ASD. The reduction in GSH levels in

               these  brain  regions  was  attributed  to  increased  lipid  peroxidation  and  deficiencies  in

               mitochondrial electron transport chain (ETC) complexes, indicating increased oxidative
               damage  and  mitochondrial  dysfunction  in  autism  (Chauhan  et  al.,  2012).  Rose  et  al.

               (2012) further suggested that GSH level disturbances in the temporal cortex arise from
               increased  mitochondrial  superoxide  production  and  chronic  inflammation.  Decreased

               GSH availability in the brains of individuals with autism suggests disrupted mitochondrial
               redox balance, which may promote mitochondrial damage via elevated ROS, negatively

               affecting cellular energy production and leading to cell death (Ayer et al., 2010). In the
               present study, decreased GSH and GPX1 levels in the autism group compared to controls

               parallel these previous findings.
                     Malondialdehyde  (MDA)  is  the  end  product  of  polyunsaturated  fatty  acid

               peroxidation and serves as a biomarker for lipid peroxidation. Measurement of MDA levels

               is one of the most commonly used methods to assess lipid peroxidation (Yui et al., 2020).
               Various studies on children diagnosed with ASD have reported increased MDA levels in

               plasma (Meguid et al., 2011; Essa et al., 2012; Altun et al., 2018; Yui et al., 2020) and
               brain tissue (Bhat et al., 2023). Altun et al. (2018) reported a positive correlation between

               elevated MDA levels and the severity of ASD symptoms, suggesting that individuals with
               higher  MDA  may  have  more  severe  forms  of  the  disorder  (Altun  et  al.,  2018).  In  the

               present study, a significant increase in MDA levels was observed in ASD, consistent with
               the literature.

                     Catalase (CAT) reduces the toxicity of hydrogen peroxide (H₂O₂) by converting it into

               water and oxygen, whereas glutathione peroxidase (GPx) reduces hydrogen peroxide and
               organic hydroperoxides to water or corresponding alcohols using glutathione (GSH) as an


                                                                                                        42
   39   40   41   42   43   44   45   46   47   48   49